Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLA.L Regulatory News (SLA)

  • There is currently no data for SLA

Share Repurchase Programme - Replacement

1 Oct 2020 10:06

RNS Number : 7958A
Standard Life Aberdeen plc
01 October 2020
 

 

The following amendments have been made to the 'Extension of Share Repurchase Programme' announcement released on 1 October 2020 at 08.00 under RNS No 6914A.

 

The Company has agreed with JPMS plc to extend and continue the Programme from 1 October 2020 until 28 February 2021.

 

As such, the aggregate consideration to be purchased by JPMS plc under the extension of the Programme shall be no greater than £400m less any amount of Shares previously purchased during the period from 10 February 2020 to 30 September 2020, such that the overall aggregate consideration to be purchased between 10 February 2020 and 28 February 2021 under the Programme

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

Standard Life Aberdeen plc ("the Company")

 

Extension of Share Repurchase Programme (the "Programme")

On 7 February 2020 the Company announced that it had entered into a non-discretionary instruction with J.P. Morgan Securities plc ("JPMS plc ") in relation to the purchase by JPMS plc, acting as riskless principal, of ordinary shares in the Company's share capital (the "Shares") for an aggregate consideration of no greater than £400m, to take place during the period commencing on 10 February 2020 and ending no later than 30 September 2020.

 

The Programme has, at 30 September 2020, resulted in the purchase of Shares for an aggregate consideration of approximately £279m.

 

Consequently, the Company today announces that it has agreed with JPMS plc to extend and continue the Programme from 1 October 2020 until 28 February 2021, under similar non-discretionary terms as instructed in relation to the original Programme. As such, the aggregate consideration to be purchased by JPMS plc under the extension of the Programme shall be no greater than £400m less any amount of Shares previously purchased during the period from 10 February 2020 to 30 September 2020, such that the overall aggregate consideration to be purchased between 10 February 2020 and 28 February 2021 under the Programme and the extension to the Programme shall be no greater than £400m.

 

Any purchase of Shares done in relation to this announcement will be carried out on the London Stock Exchange and executed in accordance with the Listing Rules and the Company's authority to make market purchases of Shares, as granted at the Company's 2020 annual general meeting on 14 May 2020 (which was granted on the similar terms as the previous authority granted by shareholders at its 2019 annual general meeting). The Company will announce any market repurchase of Shares no later than 7.30 am on the business day following the calendar day on which the repurchase occurred. The purpose of the Programme is to reduce the share capital of the Company. All Shares purchased will be cancelled.

 

The total number of voting rights in the Company as at 30 September 2020 is 2,225,782,374.

1 October 2020

Enquiries:

 

Institutional Equity Investors

Catherine Nash

 

 

Neil Longair

 

 

+44 (0) 207 463 6371

+44 (0) 779 851 8657

 

+44 (0) 131 245 6466*

+44 (0) 7711 357 595

Media

James Thorneley

 

+44 (0) 20 7463 6323

+44 (0) 7768 556 334

Group Secretariat

Paul McKenna

 

+44 (0)131 372 0703*

 

* Calls may be monitored and/or recorded to protect both you and us and help with our training. Call charges will vary.

 

LEI: OTMBS544NMO7GLCE7H90

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMBBLTMTMMMBM
Date   Source Headline
4th Mar 202111:58 amRNSForm 8.3 - Aggreko PLC
4th Mar 202111:57 amRNSForm 8.3 - RSA Insurance Group plc
3rd Mar 20213:52 pmRNSHolding(s) in Company
3rd Mar 202111:07 amRNSForm 8.3 - RSA Insurance Group plc
3rd Mar 20219:24 amRNSHolding(s) in Company
1st Mar 202111:18 amRNSTotal Voting Rights
1st Mar 202111:18 amRNSForm 8.3 - William Hill plc
1st Mar 202111:17 amRNSForm 8.3 - RSA Insurance Group plc
26th Feb 20215:21 pmRNSHolding(s) in Company
26th Feb 20211:31 pmRNSForm 8.3 - RSA Insurance Group plc
25th Feb 202111:48 amRNSForm 8.3 - G4S plc
25th Feb 202111:34 amRNSForm 8.3 - William Hill plc
25th Feb 202111:26 amRNSForm 8.3 - Aggreko plc
25th Feb 202111:24 amRNSForm 8.3 - RSA Insurance Group plc
23rd Feb 20217:00 amRNSUpdate on Strategic Partnership with PGH
22nd Feb 20215:26 pmRNSHolding(s) in Company
22nd Feb 202111:31 amRNSForm 8.3 - William Hill plc
22nd Feb 202111:08 amRNSForm 8.3 - RSA Insurance Group plc
19th Feb 202111:05 amRNSForm 8.3 - William Hill plc
19th Feb 202111:03 amRNSForm 8.3 - Aggreko plc
18th Feb 20214:26 pmRNSHolding(s) in Company
18th Feb 202111:06 amRNSForm 8.3 - G4S plc
18th Feb 202110:54 amRNSForm 8.3 - William Hill plc
18th Feb 202110:50 amRNSForm 8.3 - Aggreko plc
18th Feb 202110:45 amRNSForm 8.3 - RSA Insurance Group plc
17th Feb 202112:31 pmRNSForm 8.3 - Future plc
17th Feb 202112:23 pmRNSForm 8.3 - William Hill plc
17th Feb 202112:07 pmRNSForm 8.3 - RSA Insurance Group plc
17th Feb 20218:05 amRNSHolding(s) in Company
16th Feb 202112:26 pmRNSForm 8.3 - Future plc
15th Feb 202110:53 amRNSForm 8.3 - Future plc
12th Feb 20214:25 pmRNSHolding(s) in Company
12th Feb 20214:12 pmRNSHolding(s) in Company
12th Feb 20211:00 pmRNSHolding(s) in Company
12th Feb 202112:36 pmRNSForm 8.3 - Future plc
12th Feb 202112:36 pmRNSForm 8.3 - G4S plc
12th Feb 202112:33 pmRNSForm 8.3 - Aggreko plc
12th Feb 202112:33 pmRNSForm 8.3 - William Hill plc
12th Feb 202112:29 pmRNSForm 8.3 - RSA Insurance Group plc
11th Feb 202110:26 amRNSForm 8.3 - Future plc
11th Feb 202110:15 amRNSDirector Declaration
11th Feb 20217:00 amRNSTransaction in Own Shares
10th Feb 20214:50 pmRNSHolding(s) in Company
10th Feb 20213:10 pmRNSHolding(s) in Company
10th Feb 20213:08 pmRNSHolding(s) in Company
10th Feb 202110:19 amRNSForm 8.3 - Future plc
10th Feb 20217:16 amRNSNotification of Major Holding(s)
10th Feb 20217:00 amRNSTransaction in Own Shares
9th Feb 202111:27 amRNSForm 8.3 - G4S plc
9th Feb 202111:25 amRNSForm 8.3 - William Hill plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.